Schedule 13G ownership disclosure
REGENERON PHARMACEUTICALS COM
Security class unavailable · CUSIP: 75886F107
Event date: 2016-12-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,688,709
- Percent of class
- 5.4900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-17-000341
- Form type
- SC 13G
- Filer
- REGENERON PHARMACEUTICALS, INC.
- CIK
- CIK 872589
- Filed
- Feb 09, 2017
- Reporting period
- Dec 30, 2016
- Description
- Schedule 13G beneficial ownership